RBM15 and familial pancreatic carcinoma: This article reports that RBM15 is correlated with pancreatic cancer progression and is an essential prognostic biomarker in pancreatic cancer patients and is correlated with progression by bioinformatic integrated analysis, clinical information statistical analysis and wet experiments.